 |
Idarubicin HCl for injection |
|---|---|
| Trade Name | Idamycin |
| Orphan Indication | Acute myelogenous leukemia, also referred to as acute nonlymphocytic leukemia |
| USA Market Approval | USA |
| USA Designation Date | 1988-07-25 00:00:00 |
| Sponsor | Adria Laboratories, Inc.;P.O. Box 16529;Columbus, Ohio, 43216 |
